Compliance by Design
Regulatory, quality and market requirements are integrated into the project structure from the outset rather than addressed at the end of the process.
Strategic Advisory. Compliance. Market Access. For Medical Cannabis & Pharmaceuticals.
ABOUT CHK
Who We Are
CHK Solutions is an international strategic advisory company focused on medical cannabis and pharmaceutical markets.
Founded in Barcelona in 2017, CHK Solutions builds on more than a decade of industry experience across international cannabis markets, operators, technologies and regulatory environments.
Having evolved alongside the industry, CHK has progressively focused its expertise on regulated medical cannabis and pharmaceutical supply chains, combining strategic, operational and market experience developed across Europe, North America, Africa and Asia.
Today, CHK Solutions advises licensed operators, investors and project owners on the design, structuring and development of market-ready projects across regulated international markets.
Our role is strategic: we define the framework, align the required capabilities and coordinate with qualified operators, manufacturers, regulatory specialists and market-access partners according to the requirements of each project and destination market.
Our Approach
Market-Driven Structuring
Projects are structured backwards from the requirements of the destination market, downstream pharmaceutical pathway and commercial objective.
Integrated Supply Chain Thinking
Cultivation, processing, manufacturing, logistics and market access are considered as one coordinated pathway rather than isolated functions.
Long-Term Strategic Value
Projects, partnerships and operational models are structured with scalability, resilience and long-term strategic value in mind.
CONSULTINGSTRATEGY, REPRESENTATION & COMPLIANCE ENABLEMENT
Strategic Advisory for
Medical Cannabis & Pharmaceutical Markets
CHK Consulting supports licensed operators, investors and project owners in structuring compliant, market-ready projects across regulated international markets.
We combine strategic advisory with practical industry experience to define the right market position, regulatory pathway, supply-chain model and partner ecosystem for each project.
CHK does not replace licensed operators. We structure the framework, align the relevant parties and support projects from strategic definition through market readiness.
What We Do
We ensure that projects are designed correctly from the outset and executed through qualified, licensed and proven partners.
Our scope includes
- Strategic project design and market positioning
- Regulatory and compliance structuring
- Operational model definition and execution coordination
- International representation and partner enablement
View larger
- Cultivation
- Processing
- Formulation & Research
- Manufacturing
- Distribution
- Delivery + Retail
- Patient Feedback
Strategy & Market Positioning
We define clear, realistic and market-driven strategies based on each project’s objectives, jurisdiction, product category and target market.
Our work includes market-entry strategy, product positioning, portfolio development, commercial roadmaps, partner selection and long-term project structuring.
Objective: build projects around real market requirements and commercially viable pathways.
Supply Chain & Market Access
We design and coordinate international supply-chain models connecting cultivation, processing, pharmaceutical manufacturing, logistics and regulated market access.
Our approach starts with the requirements of the destination market and works backwards to ensure that each stage of the supply chain is compatible with the intended regulatory and commercial pathway.
Where required, CHK coordinates with qualified cultivation partners, manufacturers, importers, GDP operators, distributors and market-access partners.
Objective: create an execution-ready pathway from source to regulated market.
Regulatory & Compliance
We structure regulatory and quality pathways aligned with the requirements of regulated medical cannabis and pharmaceutical markets.
Our work includes GACP readiness, EU-GMP pathway definition, GDP architecture, documentation and traceability requirements, quality-system alignment and coordination with qualified regulatory specialists, auditors and pharmaceutical operators.
Objective: integrate compliance into the project architecture from the beginning and reduce regulatory and operational risk before execution.
International Representation
CHK acts as a strategic interface between projects and the international regulated cannabis ecosystem.
We support representation toward qualified operators, manufacturers, distributors, investors and market-access partners, together with strategic introductions, relationship development and commercial coordination.
CHK also helps align expectations between the different parties involved in international projects while maintaining clear responsibilities and regulatory boundaries.
Objective: connect projects with the right international partners and facilitate credible, structured market development.
Genetics
& Cultivation Strategy
CHK supports genetics sourcing, cultivar selection and cultivation strategy for regulated medical markets.
Our work focuses on genetic stability, reproducibility, agronomic performance, quality requirements, cultivation consistency and long-term market positioning.
We also support cultivation model design, phenohunting strategy, propagation planning and alignment between genetics, cultivation methods and downstream product objectives.
Objective: ensure that genetics and cultivation strategy support both regulatory requirements and commercial positioning.
CHK PHARMAMEDICAL & PHARMACEUTICAL PLATFORM
A Medical &
Pharmaceutical Platform
Building Integrated Access to Medical Cannabis & Pharmaceutical Markets
CHK Pharma is a strategic medical cannabis and pharmaceutical platform developed by CHK Solutions.
Built on CHK’s international network and regulatory expertise, the platform connects qualified cultivation, pharmaceutical manufacturing, quality, logistics and market-access capabilities across Europe and Asia.
CHK Pharma is designed to coordinate compliant international supply chains from source to regulated market, while remaining asset-light and working through selected licensed operators and strategic partners.
CHK Pharma is a separate legal entity.
Our Model
From Global Supply to Regulated Markets
CHK Pharma integrates the key components required to build compliant international medical cannabis supply chains:
Global Sourcing
Identification and qualification of cultivation partners capable of meeting regulated medical market requirements.
GACP & Quality
Cultivation programs structured around traceability, quality systems, documentation and international GACP expectations.
EU-GMP Manufacturing
Integration with qualified pharmaceutical manufacturers for processing, packaging, testing and release pathways.
GDP & Logistics
Coordination with licensed logistics and distribution infrastructure for compliant cross-border movements.
Regulatory Strategy
Development of market-specific regulatory pathways in coordination with qualified pharmaceutical and regulatory partners.
Market Access
Connection of compliant products with licensed importers, distributors, pharmacies and medical-market platforms.
The Supply Chain
Each route starts with a defined product and destination market. Product requirements, documentation and the responsible authorised operators are assessed before the route progresses.
- Qualified Cultivation
- GACP
- Processing & Testing
- EU-GMP Manufacturing
- GDP Logistics
- Licensed Distribution
- Market Access
CHK Pharma coordinates the interfaces between each stage of the supply chain, ensuring that product strategy, quality requirements, regulatory pathways and commercial objectives are aligned from the outset. The applicable route depends on the product and destination market. Regulated activities remain the responsibility of the operators holding the relevant authorisations.
CHK Solutions Strategic advisoryCHK Pharma Commercial and supply chain coordinationIndependent operators Regulated execution
Product Capabilities
Medical Cannabis & Pharmaceutical Products
The platform's product scope covers the following categories, with manufacturing and regulated activities performed by appropriately authorised partners. Availability is assessed for each product and destination market.
View product categories
Medical Cannabis Flower
Qualified medical cannabis flower for regulated international markets.
Bulk Flower for Pharmaceutical Processing
GACP-aligned starting material for downstream EU-GMP processing.
Biomass for Extraction
Qualified biomass for cannabinoid extraction and pharmaceutical processing.
Cannabinoid Extracts & Intermediates
Crude extracts, distillates, isolates and other pharmaceutical intermediates through qualified partners.
Finished Pharmaceutical Products
Development and access to finished dosage forms through licensed manufacturing partners.
Private Label & Brand Development
Development of selected medical cannabis products and future proprietary or private-label portfolios.
International Market Access
Connecting Supply with Regulated Demand
CHK Pharma is developing supply and market-access capabilities across selected regulated markets, with a particular focus on:
- Germany
- United Kingdom
- Switzerland
- Spain
- Czech Republic
- Thailand
Additional regulated markets under development
Thailand Supply Strategy
Building Qualified Supply at Source
CHK has conducted extensive market mapping across Thailand, assessing more than 50 cultivation and processing operations with a focus on infrastructure, quality systems, compliance readiness, scalability and international market potential.
This field-driven approach allows CHK Pharma to identify and develop supply relationships with operators capable of progressing toward international medical and pharmaceutical requirements.
- Farm Qualification
- GACP Readiness
- Quality Systems
- International Integration
Why CHK Pharma
Global Supply Network
Access to qualified cultivation and production opportunities across multiple international markets.
Pharmaceutical Integration
Connection with EU-GMP manufacturing, laboratories, QPs, GDP and licensed pharmaceutical infrastructure.
Regulatory Intelligence
Supply chains structured backwards from the requirements of the destination market.
Market Access
Commercial relationships and market infrastructure connecting qualified supply with regulated demand.
Built by CHK Solutions
CHK Pharma brings together the regulatory, commercial and international capabilities developed by CHK Solutions over more than a decade in the global cannabis industry.
From cultivation and genetics to processing, pharmaceutical manufacturing and international market development, CHK Pharma represents the operational application of CHK Solutions’ strategic expertise.
CHK Pharma Leadership
Jamie Pearson
CEO
Biography
Founder of New Holland Group; former President & CEO of Bhang; NCIA board. Commercial opportunities, licensing and M&A.
Cédric Pérès
CO-FOUNDER & CO-CEO
Biography
15+ years in the cannabis industry. Founder of Choko Barcelona and CEO of CHK Solutions. Architect of compliant international supply chains, strategic sourcing and global partnerships.
Rachel Wright
CFO & TAX STRATEGY
Biography
Financial and tax structuring. CPA, MST; Founder & CEO, Verdant Strategies; audit-committee chair for a public cannabis company.
NURI CHOREMI
Co-Founder & Head of Operations
Biography
Co-Founder of CHK Solutions. Over a decade analysing regulated cannabis markets, with a focus on strategic development, operational planning and execution.
Sam Ford Collins
BRAND & COMMERCIAL
Biography
20+ years luxury-brand marketing in wine and spirits. Brand strategy, commercial positioning and market development.
Our Objective
Our objective is to build a scalable international medical cannabis platform connecting high-quality global supply with regulated pharmaceutical markets.
By integrating specialised partners rather than duplicating infrastructure, CHK Pharma is designed to create an efficient, resilient and internationally scalable supply-chain model.
Building the Next Generation of International Medical Cannabis Supply Chains
For strategic partnerships, supply opportunities and regulated market development:
Our Journey
From hands-on cannabis operations and early North American market immersion to regulated medical and pharmaceutical supply chains, CHK has evolved alongside the international cannabis industry for more than a decade.
2013 — Industry Foundations
The foundations of CHK’s industry experience began with the creation of Choko Barcelona, one of Barcelona’s pioneering cannabis social clubs.
Read more
Over the following years, Choko developed into an international meeting point for entrepreneurs, investors, operators and early cannabis industry leaders from Europe and North America.
2016 — Arcview at Choko Barcelona
Choko Barcelona hosted an Arcview gathering bringing together influential figures from the emerging North American and European cannabis industries.
This period created direct relationships with people including:
- Lorne Gertner
- Steve DeAngelo
- Jamie Pearson
- Barbara Koz Paley
Several of these relationships would later become part of the wider CHK international network.
2016 — Canadian Regulated Market Immersion
Through the relationship with Lorne Gertner and the Tokyo Smoke ecosystem, we gained direct exposure to Canada’s emerging regulated cannabis market.
Read more
This included visits to major licensed cultivation and production operators including:
- Canopy Growth
- Aurora Cannabis
- Aphria
The objective was to understand licensed production, corporate cannabis structures, branding, retail models and the development of a nationally regulated market.
2017 — California & U.S. Market Immersion
We then expanded the work into California.
This included direct engagement with Steve DeAngelo and the Harborside ecosystem, combined with extensive travel and site visits across California.
We visited large cultivation operations, extraction facilities, laboratories, dispensaries and vertically integrated cannabis businesses, including major cultivation operations around Salinas.
This was not simply networking. The objective was to understand the entire legal cannabis ecosystem first-hand:
- Cultivation
- Genetics
- Testing & data
- Extraction
- Manufacturing
- Branding
- Distribution
- Retail
2017 — CHK Solutions Founded
CHK Solutions was formally established in Barcelona in 2017 to connect international expertise, technologies, brands and market opportunities across the rapidly professionalising global cannabis industry.
Read more
2017–2021 — International Industry Expansion
During this phase, CHK expanded its activities across Europe and North America.
Our activities included:
international brand representation, cultivation technologies, processing equipment, extraction systems, logistics, distribution, product development, white label and European market entry.
2022 — Expansion into Medical Cannabis
From 2022, CHK moved deeper into regulated medical cannabis.
Read more
We conducted extensive visits and assessments of medical cannabis operations, particularly in Portugal, analysing cultivation sites, infrastructure, GACP readiness, processing, quality systems and pharmaceutical pathways.
This marked the transition from the wider cannabis industry into regulated medical and pharmaceutical supply chains.
2024 — Morocco Market Development
From 2024, CHK established an active presence in Morocco.
Read more
CHK has provided strategic advisory and project structuring support to Moroccan cannabis companies.
The work includes operational structuring, international positioning, compliance readiness and preparation for regulated medical markets.
2025 — Thailand Market Entry
In 2025, CHK began an extensive analysis of the Thai cannabis industry.
Read more
The objective was not simply to source flowers but to understand the entire ecosystem and identify which operators had the infrastructure, management, quality and scalability required to participate in future regulated international markets.
2025–2026 — Thailand Market Development
CHK visited and assessed more than 50 farms and cannabis operations across Thailand.
We analysed:
- cultivation quality
- infrastructure
- environmental controls
- genetics
- processing
- quality systems
- documentation
- compliance readiness
- scalability
- international market potential
This enabled us to identify the operators best positioned to participate in future medical and pharmaceutical supply chains.
CHK Pharma development
CHK Pharma is the strategic medical cannabis and pharmaceutical platform developed by CHK Solutions, connecting supply chain planning with market requirements.
Selected Industry Experience
Selected companies, technologies and brands we have worked with throughout CHK’s development.
Historical brands and technologies we worked with included, among others:
For the brands listed below, CHK acted as a European representative and/or was among the first to bring them to the European market.
- Triminator
- PurePressure
- Bruteless
- GreenBroz
- Lemon Tree
- GoldDrop
- CannaCraft
Historical inclusion does not indicate a current partnership, endorsement or exclusive relationship.
Historical Field Experience
Steep Hill Labs — Science, Testing & Data
During this period, we also developed a strong relationship with Steep Hill Labs and Dr. Reggie Gaudino.
This provided early exposure to cannabis analytics, laboratory testing, cannabinoid and terpene data, genetics and evidence-based cannabis education.
This scientific and data-driven approach became an important part of CHK’s understanding of quality and professionalisation within the cannabis industry.
CannaCraft & Ned Fussell — Vertical Business Models
Meetings and site visits with Ned Fussell, co-founder of CannaCraft, gave us direct exposure to vertically integrated cannabis businesses.
We studied how cultivation, manufacturing, product development, brand architecture and commercialisation could operate within one integrated business model.
California Brands & Product Innovation
During the same period, CHK developed relationships with leading California brands and operators including:
- Lemon Tree
- GoldDrop
- CannaCraft
This gave us direct exposure to premium flower positioning, extraction, concentrates, product innovation and brand development.
2019–2021 — Products, White Label & European Market Development
During this period, CHK also worked on:
- CBD and cannabinoid products
- CBD/CBG flowers
- white-label product development
- contract manufacturing
- packaging
- European logistics
- brand development
- digital marketing
- European market-entry strategy
This history is useful because it demonstrates that CHK has worked across almost the entire cannabis value chain.
Global Industry Presence
Years of participation in international industry forums have connected the CHK team with operators, technologies and emerging regulatory models.
2017 — Arcview Investor Forum, Barcelona
CHK supported the Arcview Investor Forum in Barcelona in 2017.
This was one of the early milestones positioning CHK within the international cannabis investment and business ecosystem.
2017–Today — MJBizCon, Las Vegas
CHK has maintained a presence at MJBizCon since 2017.
This has allowed us to remain directly connected with international operators, investors, brands, technology companies and industry leaders.
Spannabis — Barcelona
CHK had a multi-year presence at Spannabis as sponsor and exhibitor.
We had dedicated booths presenting international brands, cultivation technologies, processing equipment and partners.
ICBC — Barcelona & Berlin
CHK has also maintained a long-standing presence within the ICBC ecosystem in Barcelona and Berlin, including industry networking and speaking engagements.
2018 — Expogrow B2B, Barcelona
CHK became one of the founding members of Spain’s first Expogrow B2B cannabis industry networking event.
CHK brought Steep Hill Labs and Dr. Reggie Gaudino to Barcelona and facilitated engagement between the international cannabis industry and established Spanish pharmaceutical and laboratory organisations, including Alcaliber.
CHK Solutions Team
With a multicultural, multilinguistic and multi-disciplinary team and the collaboration of our partners around the world, we are able to operate on an international level.
Executive Management
Cédric Peres
Founder & Chief Executive Officer
Nuri Choremi
Co-Founder & Operations Lead
Board & Strategic Leadership
Jamie L. Pearson
Board Member & Strategic Advisor
Lorne Gertner
Board Advisor
Core Strategy & Operations
Lorenzo Garrido
Director Strategic Structuring
Benjamin Dez
Director Commercial Strategy
Technical & Country Operations
Ana Albarran
Advisor Cultivation & Genetics
David Torres
Director Cultivation & Production